
----------------------------------
original sentence: 
Dynavax and Merck Agree on Final Reimbursements | TradingMarkets.com  New ETF Book by Larry Connors Click here to read more
 Dynavax and Merck Agree on Final Reimbursements
Posted on: Mon, 15 Mar 2010 06:01:05 EDT
,  Do you know when to trade  &  ?

POS tagged sentence: 
[('Dynavax', 'NNP'), ('and', 'CC'), ('Merck', 'NNP'), ('Agree', 'NNP'), ('on', 'IN'), ('Final', 'NNP'), ('Reimbursements', 'NNP'), ('|', 'NNP'), ('TradingMarkets.com', 'NNP'), ('New', 'NNP'), ('ETF', 'NNP'), ('Book', 'NNP'), ('by', 'IN'), ('Larry', 'NNP'), ('Connors', 'NNP'), ('Click', 'NNP'), ('here', 'RB'), ('to', 'TO'), ('read', 'VB'), ('more', 'JJR'), ('Dynavax', 'NNP'), ('and', 'CC'), ('Merck', 'NNP'), ('Agree', 'NNP'), ('on', 'IN'), ('Final', 'NNP'), ('Reimbursements', 'NNP'), ('Posted', 'NNP'), ('on', 'IN'), (':', ':'), ('Mon', 'NNP'), (',', ','), ('15', 'CD'), ('Mar', 'NNP'), ('2010', 'CD'), ('06', 'CD'), (':', ':'), ('01', 'CD'), (':', ':'), ('05', 'CD'), ('EDT', 'NNP'), (',', ','), ('Do', 'NNP'), ('you', 'PRP'), ('know', 'VB'), ('when', 'WRB'), ('to', 'TO'), ('trade', 'VB'), ('&', 'CC'), ('?', '.')]


ERTAGGED sentence: (S   (GPE Dynavax/NNP)   and/CC   (PERSON Merck/NNP Agree/NNP)   on/IN   Final/NNP   Reimbursements/NNP   |/NNP   TradingMarkets.com/NNP   New/NNP   ETF/NNP   Book/NNP   by/IN   (PERSON Larry/NNP Connors/NNP Click/NNP)   here/RB   to/TO   read/VB   more/JJR   (PERSON Dynavax/NNP)   and/CC   (PERSON Merck/NNP Agree/NNP)   on/IN   Final/NNP   Reimbursements/NNP   Posted/NNP   on/IN   :/:   (PERSON Mon/NNP)   ,/,   15/CD   Mar/NNP   2010/CD   06/CD   :/:   01/CD   :/:   05/CD   EDT/NNP   ,/,   Do/NNP   you/PRP   know/VB   when/WRB   to/TO   trade/VB   &/CC   ?/.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB read/VB more/JJR Dynavax/NNP)
	(VERB know/VB)
	(VERB trade/VB)
noun phrases to consider:
	(NOUN Dynavax/NNP)
	(NOUN Merck/NNP Agree/NNP)
	(NOUN Final/NNP Reimbursements/NNP |/NNP TradingMarkets.com/NNP)
	(NOUN New/NNP ETF/NNP Book/NNP)
	(NOUN Larry/NNP Connors/NNP Click/NNP)
	(NOUN Merck/NNP Agree/NNP)
	(NOUN Final/NNP Reimbursements/NNP Posted/NNP)
	(NOUN Mon/NNP)
	(NOUN 15/CD Mar/NNP)
	(NOUN 05/CD EDT/NNP)
	(NOUN Do/NNP)

----------------------------------
original sentence: 
Check for a  from TradingMarkets  BERKELEY, CA, Mar 15, 2010 MARKETWIRE via COMTEX Dynavax Technologies Corporation NASDAQ:  announced today the successful completion of negotiations relating to Merck's reimbursement obligations under the former partnership agreements covering the clinical development and commercialization of HEPLISAV TM , Dynavax's enhanced hepatitis B vaccine.

POS tagged sentence: 
[('Check', 'NNP'), ('for', 'IN'), ('a', 'DT'), ('from', 'IN'), ('TradingMarkets', 'NNPS'), ('BERKELEY', 'NNP'), (',', ','), ('CA', 'NNP'), (',', ','), ('Mar', 'NNP'), ('15', 'CD'), (',', ','), ('2010', 'CD'), ('MARKETWIRE', 'NNP'), ('via', 'IN'), ('COMTEX', 'NNP'), ('Dynavax', 'NNP'), ('Technologies', 'NNPS'), ('Corporation', 'NNP'), ('NASDAQ', 'NNP'), (':', ':'), ('announced', 'VBD'), ('today', 'NN'), ('the', 'DT'), ('successful', 'JJ'), ('completion', 'NN'), ('of', 'IN'), ('negotiations', 'NNS'), ('relating', 'VBG'), ('to', 'TO'), ('Merck', 'NNP'), ("'s", 'POS'), ('reimbursement', 'NN'), ('obligations', 'NNS'), ('under', 'IN'), ('the', 'DT'), ('former', 'JJ'), ('partnership', 'NN'), ('agreements', 'NNS'), ('covering', 'VBG'), ('the', 'DT'), ('clinical', 'JJ'), ('development', 'NN'), ('and', 'CC'), ('commercialization', 'NN'), ('of', 'IN'), ('HEPLISAV', 'NNP'), ('TM', 'NNP'), (',', ','), ('Dynavax', 'NNP'), ("'s", 'POS'), ('enhanced', 'VBN'), ('hepatitis', 'NNS'), ('B', 'NNP'), ('vaccine', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Check/NNP)   for/IN   a/DT   from/IN   (ORGANIZATION TradingMarkets/NNPS)   (ORGANIZATION BERKELEY/NNP)   ,/,   (ORGANIZATION CA/NNP)   ,/,   Mar/NNP   15/CD   ,/,   2010/CD   (ORGANIZATION MARKETWIRE/NNP)   via/IN   (ORGANIZATION     COMTEX/NNP     Dynavax/NNP     Technologies/NNPS     Corporation/NNP)   NASDAQ/NNP   :/:   announced/VBD   today/NN   the/DT   successful/JJ   completion/NN   of/IN   negotiations/NNS   relating/VBG   to/TO   (PERSON Merck/NNP)   's/POS   reimbursement/NN   obligations/NNS   under/IN   the/DT   former/JJ   partnership/NN   agreements/NNS   covering/VBG   the/DT   clinical/JJ   development/NN   and/CC   commercialization/NN   of/IN   (ORGANIZATION HEPLISAV/NNP)   TM/NNP   ,/,   (PERSON Dynavax/NNP)   's/POS   enhanced/VBN   hepatitis/NNS   B/NNP   vaccine/NN   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   announced/VBD   today/NN   the/DT   successful/JJ   completion/NN   of/IN   negotiations/NNS)
	(VERB relating/VBG to/TO Merck/NNP)
	(VERB covering/VBG the/DT clinical/JJ development/NN)
	(VERB enhanced/VBN hepatitis/NNS B/NNP vaccine/NN)
noun phrases to consider:
	(NOUN Check/NNP)
	(NOUN TradingMarkets/NNPS BERKELEY/NNP)
	(NOUN CA/NNP)
	(NOUN Mar/NNP)
	(NOUN 2010/CD MARKETWIRE/NNP)
	(NOUN COMTEX/NNP Dynavax/NNP Technologies/NNPS Corporation/NNP)
	(NOUN NASDAQ/NNP)
	(NOUN reimbursement/NN obligations/NNS)
	(NOUN the/DT former/JJ partnership/NN agreements/NNS)

tagged sentence:
	 the former partnership agreements	res:1
	(NOUN commercialization/NN)
	(NOUN HEPLISAV/NNP TM/NNP)
	(NOUN Dynavax/NNP)

----------------------------------
original sentence: 
Merck has agreed to make a $4.0 million payment to Dynavax covering expenses for the wind down period that followed its December 2008 written notification of the collaboration's conclusion.

POS tagged sentence: 
[('Merck', 'NNP'), ('has', 'VBZ'), ('agreed', 'VBN'), ('to', 'TO'), ('make', 'VB'), ('a', 'DT'), ('$', '$'), ('4.0', 'CD'), ('million', 'CD'), ('payment', 'NN'), ('to', 'TO'), ('Dynavax', 'NNP'), ('covering', 'NN'), ('expenses', 'NNS'), ('for', 'IN'), ('the', 'DT'), ('wind', 'NN'), ('down', 'IN'), ('period', 'NN'), ('that', 'IN'), ('followed', 'VBN'), ('its', 'PRP$'), ('December', 'NNP'), ('2008', 'CD'), ('written', 'VBN'), ('notification', 'NN'), ('of', 'IN'), ('the', 'DT'), ('collaboration', 'NN'), ("'s", 'POS'), ('conclusion', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Merck/NNP)   has/VBZ   agreed/VBN   to/TO   make/VB   a/DT   $/$   4.0/CD   million/CD   payment/NN   to/TO   (GPE Dynavax/NNP)   covering/NN   expenses/NNS   for/IN   the/DT   wind/NN   down/IN   period/NN   that/IN   followed/VBN   its/PRP$   December/NNP   2008/CD   written/VBN   notification/NN   of/IN   the/DT   collaboration/NN   's/POS   conclusion/NN   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB has/VBZ agreed/VBN)
	(VERB make/VB a/DT)
	(VERB followed/VBN its/PRP$ December/NNP 2008/CD)
	(VERB written/VBN notification/NN of/IN the/DT collaboration/NN)
noun phrases to consider:
	(NOUN Merck/NNP)
	(NOUN million/CD payment/NN)
	(NOUN Dynavax/NNP covering/NN expenses/NNS)
	(NOUN wind/NN)
	(NOUN period/NN)
	(NOUN conclusion/NN)

----------------------------------
original sentence: 
HEPLISAV is an investigational adult hepatitis B vaccine.

POS tagged sentence: 
[('HEPLISAV', 'NNP'), ('is', 'VBZ'), ('an', 'DT'), ('investigational', 'JJ'), ('adult', 'NN'), ('hepatitis', 'NNS'), ('B', 'NNP'), ('vaccine', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (ORGANIZATION HEPLISAV/NNP)   is/VBZ   an/DT   investigational/JJ   adult/NN   hepatitis/NNS   B/NNP   vaccine/NN   ./.)
----------------------------------
original sentence: 
The vaccine candidate is being evaluated in two Phase 3 studies that are directed toward fulfilling licensure requirements in U.S., Canada and Europe.

POS tagged sentence: 
[('The', 'DT'), ('vaccine', 'NN'), ('candidate', 'NN'), ('is', 'VBZ'), ('being', 'VBG'), ('evaluated', 'VBN'), ('in', 'IN'), ('two', 'CD'), ('Phase', 'NNP'), ('3', 'CD'), ('studies', 'NNS'), ('that', 'WDT'), ('are', 'VBP'), ('directed', 'VBN'), ('toward', 'IN'), ('fulfilling', 'NN'), ('licensure', 'NN'), ('requirements', 'NNS'), ('in', 'IN'), ('U.S.', 'NNP'), (',', ','), ('Canada', 'NNP'), ('and', 'CC'), ('Europe', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   vaccine/NN   candidate/NN   is/VBZ   being/VBG   evaluated/VBN   in/IN   two/CD   Phase/NNP   3/CD   studies/NNS   that/WDT   are/VBP   directed/VBN   toward/IN   fulfilling/NN   licensure/NN   requirements/NNS   in/IN   (GPE U.S./NNP)   ,/,   (GPE Canada/NNP)   and/CC   (GPE Europe/NNP)   ./.)
----------------------------------
original sentence: 
In a completed pivotal Phase 3 trial, HEPLISAV demonstrated increased, rapid protection with fewer doses than current licensed vaccines.

POS tagged sentence: 
[('In', 'IN'), ('a', 'DT'), ('completed', 'VBN'), ('pivotal', 'JJ'), ('Phase', 'NNP'), ('3', 'CD'), ('trial', 'NN'), (',', ','), ('HEPLISAV', 'NNP'), ('demonstrated', 'VBD'), ('increased', 'VBN'), (',', ','), ('rapid', 'JJ'), ('protection', 'NN'), ('with', 'IN'), ('fewer', 'JJR'), ('doses', 'NNS'), ('than', 'IN'), ('current', 'JJ'), ('licensed', 'VBN'), ('vaccines', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   In/IN   a/DT   completed/VBN   pivotal/JJ   Phase/NNP   3/CD   trial/NN   ,/,   (ORGANIZATION HEPLISAV/NNP)   demonstrated/VBD   increased/VBN   ,/,   rapid/JJ   protection/NN   with/IN   fewer/JJR   doses/NNS   than/IN   current/JJ   licensed/VBN   vaccines/NNS   ./.)
----------------------------------
original sentence: 
Dynavax has worldwide commercial rights to HEPLISAV and is developing the vaccine for large, high value populations that are less responsive to current licensed vaccines, including individuals with chronic kidney disease.

POS tagged sentence: 
[('Dynavax', 'NNP'), ('has', 'VBZ'), ('worldwide', 'VBN'), ('commercial', 'JJ'), ('rights', 'NNS'), ('to', 'TO'), ('HEPLISAV', 'NNP'), ('and', 'CC'), ('is', 'VBZ'), ('developing', 'VBG'), ('the', 'DT'), ('vaccine', 'NN'), ('for', 'IN'), ('large', 'JJ'), (',', ','), ('high', 'JJ'), ('value', 'NN'), ('populations', 'NNS'), ('that', 'WDT'), ('are', 'VBP'), ('less', 'RBR'), ('responsive', 'JJ'), ('to', 'TO'), ('current', 'JJ'), ('licensed', 'VBN'), ('vaccines', 'NNS'), (',', ','), ('including', 'VBG'), ('individuals', 'NNS'), ('with', 'IN'), ('chronic', 'JJ'), ('kidney', 'NN'), ('disease', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Dynavax/NNP)   has/VBZ   worldwide/VBN   commercial/JJ   rights/NNS   to/TO   (ORGANIZATION HEPLISAV/NNP)   and/CC   is/VBZ   developing/VBG   the/DT   vaccine/NN   for/IN   large/JJ   ,/,   high/JJ   value/NN   populations/NNS   that/WDT   are/VBP   less/RBR   responsive/JJ   to/TO   current/JJ   licensed/VBN   vaccines/NNS   ,/,   including/VBG   individuals/NNS   with/IN   chronic/JJ   kidney/NN   disease/NN   ./.)
----------------------------------
original sentence: 
HEPLISAV combines hepatitis B surface antigen with a proprietary Toll like Receptor 9 agonist known as ISS to enhance the immune response.

POS tagged sentence: 
[('HEPLISAV', 'NNP'), ('combines', 'VBZ'), ('hepatitis', 'NNS'), ('B', 'NNP'), ('surface', 'NN'), ('antigen', 'NN'), ('with', 'IN'), ('a', 'DT'), ('proprietary', 'JJ'), ('Toll', 'NNP'), ('like', 'IN'), ('Receptor', 'NNP'), ('9', 'CD'), ('agonist', 'NN'), ('known', 'VBN'), ('as', 'IN'), ('ISS', 'NNP'), ('to', 'TO'), ('enhance', 'VB'), ('the', 'DT'), ('immune', 'NN'), ('response', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (ORGANIZATION HEPLISAV/NNP)   combines/VBZ   hepatitis/NNS   B/NNP   surface/NN   antigen/NN   with/IN   a/DT   proprietary/JJ   Toll/NNP   like/IN   Receptor/NNP   9/CD   agonist/NN   known/VBN   as/IN   (ORGANIZATION ISS/NNP)   to/TO   enhance/VB   the/DT   immune/NN   response/NN   ./.)
----------------------------------
original sentence: 
About Hepatitis B Vaccines Currently available hepatitis B vaccines require three doses over six months to achieve full immunogenicity in healthy patient populations.

POS tagged sentence: 
[('About', 'IN'), ('Hepatitis', 'NNP'), ('B', 'NNP'), ('Vaccines', 'NNP'), ('Currently', 'NNP'), ('available', 'JJ'), ('hepatitis', 'NNS'), ('B', 'NNP'), ('vaccines', 'NNS'), ('require', 'VBP'), ('three', 'CD'), ('doses', 'NNS'), ('over', 'IN'), ('six', 'CD'), ('months', 'NNS'), ('to', 'TO'), ('achieve', 'VB'), ('full', 'JJ'), ('immunogenicity', 'NN'), ('in', 'IN'), ('healthy', 'JJ'), ('patient', 'NN'), ('populations', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   About/IN   (PERSON Hepatitis/NNP)   B/NNP   (PERSON Vaccines/NNP Currently/NNP)   available/JJ   hepatitis/NNS   B/NNP   vaccines/NNS   require/VBP   three/CD   doses/NNS   over/IN   six/CD   months/NNS   to/TO   achieve/VB   full/JJ   immunogenicity/NN   in/IN   healthy/JJ   patient/NN   populations/NNS   ./.)
----------------------------------
original sentence: 
Because compliance with this vaccine regimen is low, new vaccines are needed to provide increased protection in a shorter timeframe.

POS tagged sentence: 
[('Because', 'IN'), ('compliance', 'NN'), ('with', 'IN'), ('this', 'DT'), ('vaccine', 'NN'), ('regimen', 'NNS'), ('is', 'VBZ'), ('low', 'JJ'), (',', ','), ('new', 'JJ'), ('vaccines', 'NNS'), ('are', 'VBP'), ('needed', 'VBN'), ('to', 'TO'), ('provide', 'VB'), ('increased', 'VBN'), ('protection', 'NN'), ('in', 'IN'), ('a', 'DT'), ('shorter', 'NN'), ('timeframe', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   Because/IN   compliance/NN   with/IN   this/DT   vaccine/NN   regimen/NNS   is/VBZ   low/JJ   ,/,   new/JJ   vaccines/NNS   are/VBP   needed/VBN   to/TO   provide/VB   increased/VBN   protection/NN   in/IN   a/DT   shorter/NN   timeframe/NN   ./.)
----------------------------------
original sentence: 
Furthermore, currently available vaccines do not fully address the needs of several patient populations, including those with chronic kidney disease, HIV or chronic liver disease.

POS tagged sentence: 
[('Furthermore', 'NNP'), (',', ','), ('currently', 'RB'), ('available', 'JJ'), ('vaccines', 'NNS'), ('do', 'VBP'), ('not', 'RB'), ('fully', 'RB'), ('address', 'RB'), ('the', 'DT'), ('needs', 'NNS'), ('of', 'IN'), ('several', 'JJ'), ('patient', 'NN'), ('populations', 'NNS'), (',', ','), ('including', 'VBG'), ('those', 'DT'), ('with', 'IN'), ('chronic', 'JJ'), ('kidney', 'NN'), ('disease', 'NN'), (',', ','), ('HIV', 'NNP'), ('or', 'CC'), ('chronic', 'JJ'), ('liver', 'NN'), ('disease', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Furthermore/NNP)   ,/,   currently/RB   available/JJ   vaccines/NNS   do/VBP   not/RB   fully/RB   address/RB   the/DT   needs/NNS   of/IN   several/JJ   patient/NN   populations/NNS   ,/,   including/VBG   those/DT   with/IN   chronic/JJ   kidney/NN   disease/NN   ,/,   (ORGANIZATION HIV/NNP)   or/CC   chronic/JJ   liver/NN   disease/NN   ./.)
----------------------------------
original sentence: 
In particular, patients with comprised immune systems require both rapid and enhanced protection, either because they are less responsive to conventional vaccine regimens or because they are at high risk of infection.

POS tagged sentence: 
[('In', 'IN'), ('particular', 'JJ'), (',', ','), ('patients', 'NNS'), ('with', 'IN'), ('comprised', 'VBN'), ('immune', 'NN'), ('systems', 'NNS'), ('require', 'VBP'), ('both', 'DT'), ('rapid', 'JJ'), ('and', 'CC'), ('enhanced', 'VBD'), ('protection', 'NN'), (',', ','), ('either', 'DT'), ('because', 'IN'), ('they', 'PRP'), ('are', 'VBP'), ('less', 'RBR'), ('responsive', 'JJ'), ('to', 'TO'), ('conventional', 'JJ'), ('vaccine', 'NN'), ('regimens', 'NNS'), ('or', 'CC'), ('because', 'IN'), ('they', 'PRP'), ('are', 'VBP'), ('at', 'IN'), ('high', 'JJ'), ('risk', 'NN'), ('of', 'IN'), ('infection', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   In/IN   particular/JJ   ,/,   patients/NNS   with/IN   comprised/VBN   immune/NN   systems/NNS   require/VBP   both/DT   rapid/JJ   and/CC   enhanced/VBD   protection/NN   ,/,   either/DT   because/IN   they/PRP   are/VBP   less/RBR   responsive/JJ   to/TO   conventional/JJ   vaccine/NN   regimens/NNS   or/CC   because/IN   they/PRP   are/VBP   at/IN   high/JJ   risk/NN   of/IN   infection/NN   ./.)
----------------------------------
original sentence: 
Dynavax Technologies Corporation, a clinical stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases.

POS tagged sentence: 
[('Dynavax', 'NNP'), ('Technologies', 'NNPS'), ('Corporation', 'NNP'), (',', ','), ('a', 'DT'), ('clinical', 'JJ'), ('stage', 'NN'), ('biopharmaceutical', 'JJ'), ('company', 'NN'), (',', ','), ('discovers', 'NNS'), ('and', 'CC'), ('develops', 'NNS'), ('novel', 'NN'), ('products', 'NNS'), ('to', 'TO'), ('prevent', 'VB'), ('and', 'CC'), ('treat', 'VB'), ('infectious', 'JJ'), ('diseases', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Dynavax/NNP)   (ORGANIZATION Technologies/NNPS Corporation/NNP)   ,/,   a/DT   clinical/JJ   stage/NN   biopharmaceutical/JJ   company/NN   ,/,   discovers/NNS   and/CC   develops/NNS   novel/NN   products/NNS   to/TO   prevent/VB   and/CC   treat/VB   infectious/JJ   diseases/NNS   ./.)
----------------------------------
original sentence: 
The Company's lead product candidate is HEPLISAV, an investigational adult hepatitis B vaccine designed to enhance protection more rapidly and with fewer doses than current licensed vaccines.

POS tagged sentence: 
[('The', 'DT'), ('Company', 'NNP'), ("'s", 'POS'), ('lead', 'NN'), ('product', 'NN'), ('candidate', 'NN'), ('is', 'VBZ'), ('HEPLISAV', 'NNP'), (',', ','), ('an', 'DT'), ('investigational', 'JJ'), ('adult', 'NN'), ('hepatitis', 'NNS'), ('B', 'NNP'), ('vaccine', 'NN'), ('designed', 'VBN'), ('to', 'TO'), ('enhance', 'NN'), ('protection', 'NN'), ('more', 'RBR'), ('rapidly', 'RB'), ('and', 'CC'), ('with', 'IN'), ('fewer', 'JJR'), ('doses', 'NNS'), ('than', 'IN'), ('current', 'JJ'), ('licensed', 'VBN'), ('vaccines', 'NNS'), ('.', '.')]


ERTAGGED sentence: (S   The/DT   (ORGANIZATION Company/NNP)   's/POS   lead/NN   product/NN   candidate/NN   is/VBZ   (ORGANIZATION HEPLISAV/NNP)   ,/,   an/DT   investigational/JJ   adult/NN   hepatitis/NNS   B/NNP   vaccine/NN   designed/VBN   to/TO   enhance/NN   protection/NN   more/RBR   rapidly/RB   and/CC   with/IN   fewer/JJR   doses/NNS   than/IN   current/JJ   licensed/VBN   vaccines/NNS   ./.)
----------------------------------
original sentence: 
For more information visit www.dynavax.com.

POS tagged sentence: 
[('For', 'IN'), ('more', 'JJR'), ('information', 'NN'), ('visit', 'NN'), ('www.dynavax.com', '-NONE-'), ('.', '.')]


ERTAGGED sentence: (S   For/IN   more/JJR   information/NN   visit/NN   www.dynavax.com/-NONE-   ./.)
----------------------------------
original sentence: 
Forward looking Statements This press release contains "forward looking statements" that are subject to a number of risks and uncertainties, including statements regarding the nature of HEPLISAV clinical trials required for BLA submission.

POS tagged sentence: 
[('Forward', 'NNP'), ('looking', 'NN'), ('Statements', 'NNS'), ('This', 'DT'), ('press', 'NN'), ('release', 'NN'), ('contains', 'VBZ'), ('"', ':'), ('forward', 'RB'), ('looking', 'VBG'), ('statements', 'NNS'), ('"', ':'), ('that', 'IN'), ('are', 'VBP'), ('subject', 'JJ'), ('to', 'TO'), ('a', 'DT'), ('number', 'NN'), ('of', 'IN'), ('risks', 'NNS'), ('and', 'CC'), ('uncertainties', 'NNS'), (',', ','), ('including', 'VBG'), ('statements', 'NNS'), ('regarding', 'VBG'), ('the', 'DT'), ('nature', 'NN'), ('of', 'IN'), ('HEPLISAV', 'NNP'), ('clinical', 'JJ'), ('trials', 'NNS'), ('required', 'VBN'), ('for', 'IN'), ('BLA', 'NNP'), ('submission', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Forward/NNP)   looking/NN   Statements/NNS   This/DT   press/NN   release/NN   contains/VBZ   "/:   forward/RB   looking/VBG   statements/NNS   "/:   that/IN   are/VBP   subject/JJ   to/TO   a/DT   number/NN   of/IN   risks/NNS   and/CC   uncertainties/NNS   ,/,   including/VBG   statements/NNS   regarding/VBG   the/DT   nature/NN   of/IN   (ORGANIZATION HEPLISAV/NNP)   clinical/JJ   trials/NNS   required/VBN   for/IN   (ORGANIZATION BLA/NNP)   submission/NN   ./.)
----------------------------------
original sentence: 
Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including whether successful clinical and regulatory development and approval of HEPLISAV can occur in a timely manner or without significant additional studies or difficulties or delays in development or clinical trial enrollment, whether the studies can support registration for commercialization of HEPLISAV, the commercial potential for HEPLISAV and the Company's ability to obtain additional financing to support the development and commercialization of HEPLISAV and its other operations, possible claims against the Company based on the patent rights of others; and other risks detailed in the "Risk Factors" section of our current periodic reports with the SEC.

POS tagged sentence: 
[('Actual', 'JJ'), ('results', 'NNS'), ('may', 'MD'), ('differ', 'VB'), ('materially', 'RB'), ('from', 'IN'), ('those', 'DT'), ('set', 'NN'), ('forth', 'NN'), ('in', 'IN'), ('this', 'DT'), ('press', 'NN'), ('release', 'NN'), ('due', 'JJ'), ('to', 'TO'), ('the', 'DT'), ('risks', 'NNS'), ('and', 'CC'), ('uncertainties', 'NNS'), ('inherent', 'JJ'), ('in', 'IN'), ('our', 'PRP$'), ('business', 'NN'), (',', ','), ('including', 'VBG'), ('whether', 'IN'), ('successful', 'JJ'), ('clinical', 'JJ'), ('and', 'CC'), ('regulatory', 'JJ'), ('development', 'NN'), ('and', 'CC'), ('approval', 'NN'), ('of', 'IN'), ('HEPLISAV', 'NNP'), ('can', 'MD'), ('occur', 'VB'), ('in', 'IN'), ('a', 'DT'), ('timely', 'JJ'), ('manner', 'NN'), ('or', 'CC'), ('without', 'IN'), ('significant', 'JJ'), ('additional', 'JJ'), ('studies', 'NNS'), ('or', 'CC'), ('difficulties', 'NNS'), ('or', 'CC'), ('delays', 'NNS'), ('in', 'IN'), ('development', 'NN'), ('or', 'CC'), ('clinical', 'JJ'), ('trial', 'NN'), ('enrollment', 'NN'), (',', ','), ('whether', 'IN'), ('the', 'DT'), ('studies', 'NNS'), ('can', 'MD'), ('support', 'VB'), ('registration', 'NN'), ('for', 'IN'), ('commercialization', 'NN'), ('of', 'IN'), ('HEPLISAV', 'NNP'), (',', ','), ('the', 'DT'), ('commercial', 'JJ'), ('potential', 'NN'), ('for', 'IN'), ('HEPLISAV', 'NNP'), ('and', 'CC'), ('the', 'DT'), ('Company', 'NNP'), ("'s", 'POS'), ('ability', 'NN'), ('to', 'TO'), ('obtain', 'VB'), ('additional', 'JJ'), ('financing', 'NN'), ('to', 'TO'), ('support', 'VB'), ('the', 'DT'), ('development', 'NN'), ('and', 'CC'), ('commercialization', 'NN'), ('of', 'IN'), ('HEPLISAV', 'NNP'), ('and', 'CC'), ('its', 'PRP$'), ('other', 'JJ'), ('operations', 'NNS'), (',', ','), ('possible', 'JJ'), ('claims', 'NNS'), ('against', 'IN'), ('the', 'DT'), ('Company', 'NNP'), ('based', 'VBD'), ('on', 'IN'), ('the', 'DT'), ('patent', 'NN'), ('rights', 'NNS'), ('of', 'IN'), ('others', 'NNS'), (';', ':'), ('and', 'CC'), ('other', 'JJ'), ('risks', 'NNS'), ('detailed', 'VBD'), ('in', 'IN'), ('the', 'DT'), ('"', 'NN'), ('Risk', 'NNP'), ('Factors', 'NNP'), ('"', 'NNP'), ('section', 'NN'), ('of', 'IN'), ('our', 'PRP$'), ('current', 'JJ'), ('periodic', 'JJ'), ('reports', 'NNS'), ('with', 'IN'), ('the', 'DT'), ('SEC', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Actual/JJ)   results/NNS   may/MD   differ/VB   materially/RB   from/IN   those/DT   set/NN   forth/NN   in/IN   this/DT   press/NN   release/NN   due/JJ   to/TO   the/DT   risks/NNS   and/CC   uncertainties/NNS   inherent/JJ   in/IN   our/PRP$   business/NN   ,/,   including/VBG   whether/IN   successful/JJ   clinical/JJ   and/CC   regulatory/JJ   development/NN   and/CC   approval/NN   of/IN   (ORGANIZATION HEPLISAV/NNP)   can/MD   occur/VB   in/IN   a/DT   timely/JJ   manner/NN   or/CC   without/IN   significant/JJ   additional/JJ   studies/NNS   or/CC   difficulties/NNS   or/CC   delays/NNS   in/IN   development/NN   or/CC   clinical/JJ   trial/NN   enrollment/NN   ,/,   whether/IN   the/DT   studies/NNS   can/MD   support/VB   registration/NN   for/IN   commercialization/NN   of/IN   (ORGANIZATION HEPLISAV/NNP)   ,/,   the/DT   commercial/JJ   potential/NN   for/IN   (ORGANIZATION HEPLISAV/NNP)   and/CC   the/DT   (ORGANIZATION Company/NNP)   's/POS   ability/NN   to/TO   obtain/VB   additional/JJ   financing/NN   to/TO   support/VB   the/DT   development/NN   and/CC   commercialization/NN   of/IN   (ORGANIZATION HEPLISAV/NNP)   and/CC   its/PRP$   other/JJ   operations/NNS   ,/,   possible/JJ   claims/NNS   against/IN   the/DT   (ORGANIZATION Company/NNP)   based/VBD   on/IN   the/DT   patent/NN   rights/NNS   of/IN   others/NNS   ;/:   and/CC   other/JJ   risks/NNS   detailed/VBD   in/IN   the/DT   "/NN   (PERSON Risk/NNP)   Factors/NNP   "/NNP   section/NN   of/IN   our/PRP$   current/JJ   periodic/JJ   reports/NNS   with/IN   the/DT   (ORGANIZATION SEC/NNP)   ./.)
----------------------------------
original sentence: 
We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

POS tagged sentence: 
[('We', 'PRP'), ('undertake', 'VBP'), ('no', 'DT'), ('obligation', 'NN'), ('to', 'TO'), ('revise', 'VB'), ('or', 'CC'), ('update', 'VB'), ('information', 'NN'), ('herein', 'NN'), ('to', 'TO'), ('reflect', 'VB'), ('events', 'NNS'), ('or', 'CC'), ('circumstances', 'NNS'), ('in', 'IN'), ('the', 'DT'), ('future', 'NN'), (',', ','), ('even', 'RB'), ('if', 'IN'), ('new', 'JJ'), ('information', 'NN'), ('becomes', 'VBZ'), ('available', 'JJ'), ('.', '.')]


ERTAGGED sentence: (S   We/PRP   undertake/VBP   no/DT   obligation/NN   to/TO   revise/VB   or/CC   update/VB   information/NN   herein/NN   to/TO   reflect/VB   events/NNS   or/CC   circumstances/NNS   in/IN   the/DT   future/NN   ,/,   even/RB   if/IN   new/JJ   information/NN   becomes/VBZ   available/JJ   ./.)
----------------------------------
original sentence: 
Contact: Michael Ostrach Vice President and Chief Business Officer 510 665 7257 Email Contact SOURCE: Dynavax Technologies http://www2.marketwire.com/mw/emailprcntct?id=C27E6CAF8763EAD5 For full details on Merck & Co MRK .

POS tagged sentence: 
[('Contact', 'NN'), (':', ':'), ('Michael', 'NNP'), ('Ostrach', 'NNP'), ('Vice', 'NNP'), ('President', 'NNP'), ('and', 'CC'), ('Chief', 'NNP'), ('Business', 'NNP'), ('Officer', 'NNP'), ('510', 'CD'), ('665', 'CD'), ('7257', 'CD'), ('Email', 'NNP'), ('Contact', 'NNP'), ('SOURCE', 'NNP'), (':', ':'), ('Dynavax', 'NNP'), ('Technologies', 'NNPS'), ('http', 'NN'), (':', ':'), ('//www2.marketwire.com/mw/emailprcntct', 'JJ'), ('?', '.'), ('id', 'JJ'), ('=', 'NN'), ('C27E6CAF8763EAD5', 'NNP'), ('For', 'NNP'), ('full', 'JJ'), ('details', 'NNS'), ('on', 'IN'), ('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   (GSP Contact/NN)   :/:   (PERSON Michael/NNP Ostrach/NNP)   Vice/NNP   President/NNP   and/CC   Chief/NNP   Business/NNP   Officer/NNP   510/CD   665/CD   7257/CD   Email/NNP   Contact/NNP   SOURCE/NNP   :/:   (ORGANIZATION Dynavax/NNP Technologies/NNPS)   http/NN   :/:   //www2.marketwire.com/mw/emailprcntct/JJ   ?/.   id/JJ   =/NN   (ORGANIZATION C27E6CAF8763EAD5/NNP For/NNP)   full/JJ   details/NNS   on/IN   (ORGANIZATION Merck/NNP)   &/CC   Co/NNP   MRK/NNP   ./.)Up/down number phrases to consider:
verb phrases to consider:
noun phrases to consider:
	(NOUN Contact/NN)
	(NOUN Michael/NNP Ostrach/NNP Vice/NNP President/NNP)
	(NOUN Chief/NNP Business/NNP Officer/NNP)
	(NOUN 7257/CD Email/NNP Contact/NNP SOURCE/NNP)
	(NOUN Dynavax/NNP Technologies/NNPS http/NN)
	(NOUN //www2.marketwire.com/mw/emailprcntct/JJ)
	(NOUN id/JJ =/NN C27E6CAF8763EAD5/NNP For/NNP)
	(NOUN full/JJ details/NNS)
	(NOUN Merck/NNP)
	(NOUN Co/NNP MRK/NNP)

----------------------------------
original sentence: 
Merck & Co MRK has Short Term PowerRatings at TradingMarkets.

POS tagged sentence: 
[('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('has', 'VBZ'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('at', 'IN'), ('TradingMarkets', 'NNPS'), ('.', '.')]


ERTAGGED sentence: (S   (GPE Merck/NNP)   &/CC   Co/NNP   MRK/NNP   has/VBZ   (PERSON Short/NNP Term/NNP)   PowerRatings/NNP   at/IN   (ORGANIZATION TradingMarkets/NNPS)   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   has/VBZ   Short/NNP   Term/NNP   PowerRatings/NNP   at/IN   TradingMarkets/NNPS)
noun phrases to consider:
	(NOUN Merck/NNP)
	(NOUN Co/NNP MRK/NNP)

----------------------------------
original sentence: 
Details on Merck & Co MRK Short Term PowerRatings is available at For full details on Dynavax Tech DVAX .

POS tagged sentence: 
[('Details', 'NNS'), ('on', 'IN'), ('Merck', 'NNP'), ('&', 'CC'), ('Co', 'NNP'), ('MRK', 'NNP'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('is', 'VBZ'), ('available', 'JJ'), ('at', 'IN'), ('For', 'NNP'), ('full', 'JJ'), ('details', 'NNS'), ('on', 'IN'), ('Dynavax', 'NNP'), ('Tech', 'NNP'), ('DVAX', 'NNP'), ('.', '.')]


ERTAGGED sentence: (S   Details/NNS   on/IN   (ORGANIZATION Merck/NNP)   &/CC   Co/NNP   MRK/NNP   Short/NNP   Term/NNP   PowerRatings/NNP   is/VBZ   available/JJ   at/IN   (ORGANIZATION For/NNP)   full/JJ   details/NNS   on/IN   (PERSON Dynavax/NNP Tech/NNP)   DVAX/NNP   ./.)Up/down number phrases to consider:
verb phrases to consider:
	(VERB   is/VBZ   available/JJ   at/IN   For/NNP   full/JJ   details/NNS   on/IN   Dynavax/NNP   Tech/NNP   DVAX/NNP)
noun phrases to consider:
	(NOUN Details/NNS)
	(NOUN Merck/NNP)
	(NOUN Co/NNP MRK/NNP Short/NNP Term/NNP)
	(NOUN PowerRatings/NNP)

----------------------------------
original sentence: 
Dynavax Tech DVAX has Short Term PowerRatings at TradingMarkets.

POS tagged sentence: 
[('Dynavax', 'NNP'), ('Tech', 'NNP'), ('DVAX', 'NNP'), ('has', 'VBZ'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('at', 'IN'), ('TradingMarkets', 'NNPS'), ('.', '.')]


ERTAGGED sentence: (S   (PERSON Dynavax/NNP)   (ORGANIZATION Tech/NNP)   DVAX/NNP   has/VBZ   (PERSON Short/NNP Term/NNP)   PowerRatings/NNP   at/IN   (ORGANIZATION TradingMarkets/NNPS)   ./.)
----------------------------------
original sentence: 
Details on Dynavax Tech DVAX Short Term PowerRatings is available at Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day.

POS tagged sentence: 
[('Details', 'NNS'), ('on', 'IN'), ('Dynavax', 'NNP'), ('Tech', 'NNP'), ('DVAX', 'NNP'), ('Short', 'NNP'), ('Term', 'NNP'), ('PowerRatings', 'NNP'), ('is', 'VBZ'), ('available', 'JJ'), ('at', 'IN'), ('Learn', 'NNP'), ('new', 'JJ'), ('strategies', 'NNS'), (',', ','), ('how', 'WRB'), ('to', 'TO'), ('trade', 'VB'), ('in', 'IN'), ('this', 'DT'), ('market', 'NN'), (',', ','), ('and', 'CC'), ('the', 'DT'), ('stocks', 'NNS'), ('you', 'PRP'), ('should', 'MD'), ('be', 'VB'), ('focusing', 'VBG'), ('on', 'IN'), ('each', 'DT'), ('day', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   Details/NNS   on/IN   (PERSON Dynavax/NNP Tech/NNP)   DVAX/NNP   Short/NNP   Term/NNP   PowerRatings/NNP   is/VBZ   available/JJ   at/IN   (ORGANIZATION Learn/NNP)   new/JJ   strategies/NNS   ,/,   how/WRB   to/TO   trade/VB   in/IN   this/DT   market/NN   ,/,   and/CC   the/DT   stocks/NNS   you/PRP   should/MD   be/VB   focusing/VBG   on/IN   each/DT   day/NN   ./.)
----------------------------------
original sentence: 
Join us for our  20 minute tele seminars during the week.

POS tagged sentence: 
[('Join', 'NNP'), ('us', 'PRP'), ('for', 'IN'), ('our', 'PRP$'), ('20', 'CD'), ('minute', 'NN'), ('tele', 'NN'), ('seminars', 'NNS'), ('during', 'IN'), ('the', 'DT'), ('week', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   Join/NNP   us/PRP   for/IN   our/PRP$   20/CD   minute/NN   tele/NN   seminars/NNS   during/IN   the/DT   week/NN   ./.)
----------------------------------
original sentence: 
Thursday April 29 12:30 PM Hear What Kevin Haggerty Sees in the Stock Market Today!

POS tagged sentence: 
[('Thursday', 'NNP'), ('April', 'NNP'), ('29', 'CD'), ('12', 'CD'), (':', ':'), ('30', 'CD'), ('PM', 'NNP'), ('Hear', 'NNP'), ('What', 'NNP'), ('Kevin', 'NNP'), ('Haggerty', 'NNP'), ('Sees', 'NNP'), ('in', 'IN'), ('the', 'DT'), ('Stock', 'NNP'), ('Market', 'NNP'), ('Today', 'NNP'), ('!', '.')]


ERTAGGED sentence: (S   Thursday/NNP   April/NNP   29/CD   12/CD   :/:   30/CD   PM/NNP   Hear/NNP   What/NNP   (PERSON Kevin/NNP Haggerty/NNP Sees/NNP)   in/IN   the/DT   Stock/NNP   (PERSON Market/NNP)   Today/NNP   !/.)
----------------------------------
original sentence: 
Wednesday April 28 01:00 PM Hear What Gary Kaltbaum Sees in the Stock Market Today!

POS tagged sentence: 
[('Wednesday', 'NNP'), ('April', 'NNP'), ('28', 'CD'), ('01', 'CD'), (':', ':'), ('00', 'CD'), ('PM', 'NNP'), ('Hear', 'NNP'), ('What', 'NNP'), ('Gary', 'NNP'), ('Kaltbaum', 'NNP'), ('Sees', 'NNP'), ('in', 'IN'), ('the', 'DT'), ('Stock', 'NNP'), ('Market', 'NNP'), ('Today', 'NNP'), ('!', '.')]


ERTAGGED sentence: (S   Wednesday/NNP   April/NNP   28/CD   01/CD   :/:   00/CD   PM/NNP   Hear/NNP   What/NNP   Gary/NNP   Kaltbaum/NNP   Sees/NNP   in/IN   the/DT   Stock/NNP   (PERSON Market/NNP)   Today/NNP   !/.)
----------------------------------
original sentence: 
* Attendance is strictly limited and are filled on a first come, first served basis. 

POS tagged sentence: 
[('*', '-NONE-'), ('Attendance', 'VB'), ('is', 'VBZ'), ('strictly', 'RB'), ('limited', 'VBN'), ('and', 'CC'), ('are', 'VBP'), ('filled', 'VBN'), ('on', 'IN'), ('a', 'DT'), ('first', 'JJ'), ('come', 'NN'), (',', ','), ('first', 'JJ'), ('served', 'VBD'), ('basis', 'NN'), ('.', '.')]


ERTAGGED sentence: (S   */-NONE-   Attendance/VB   is/VBZ   strictly/RB   limited/VBN   and/CC   are/VBP   filled/VBN   on/IN   a/DT   first/JJ   come/NN   ,/,   first/JJ   served/VBD   basis/NN   ./.)

veryneg:0	neg:0	pos:1	verypos:0	total:1